OSCR

Spinal mechanisms and feasibility of Dry Needling versus Botulinum Toxin Type A in post-stroke lower limb spasticity: A proof-of-concept randomized clinical trial protocol (STROKE-POC).

Overview

Authors: Clara Pujol-Fuentes1,2, Bart Eeckhaut3, Samuel Fernández Carnero4, Daniel Fernández Sanchís2,5, Theodore Wein6, Pablo Herrero2,7, Wim Saeys3, Mindy F Levin8,9
  1. Faculty of Health and Sciences, Department of Physiotherapy, Universidad Europea de Valencia‌‌, Valencia, Spain
  2. Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain
  3. Faculty of Health Sciences and Medicine, Department of Rehabilitation Sciences and Physiotherapy‌‌, University of Antwerp, Antwerp, Belgium
  4. Universidad de Alcalá, Facultad de Medicina y Ciencias de la Salud, Departamento de Enfermería y Fisioterapia, Grupo de Investigación Fisioterapia y Dolor, Alcalá de Henares, Spain
  5. Faculty of Health Sciences, Universidad San Jorge, Villanueva de Gállego, Zaragoza, Spain
  6. Faculty of Medicine, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
  7. Faculty of Health Sciences, Department of Physiotherapy, Universidad de Zaragoza, Zaragoza, Spain
  8. McGill University, School of Physical and Occupational Therapy, Montreal, Quebec, Canada
  9. Center for Interdisciplinary Research in Rehabilitation of Greater Montreal (CRIR), Montreal, Quebec, Canada
Journal: PloS one, volume 21, issue 5, article e0334571
Dates: received 18 November 2025; accepted 10 April 2026; published online 20 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1371/journal.pone.0334571 · PMID 42160369 · PMCID PMC13189288 · OpenAlex W7161800842
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), stroke (population), clinical / translational (subfield)
Methods: Statistics, Physiology & signal measures
MeSH: Botulinum Toxins, Type A*, Dry Needling*, Lower Extremity*, Muscle Spasticity*, Stroke*, Adult, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Cost-Benefit Analysis, Feasibility Studies, Female, Humans, Male, Middle Aged, Multicenter Studies as Topic, Proof of Concept Study, Quality of Life, Randomized Controlled Trials as Topic, Treatment Outcome (* major topic)
Topic: Botulinum Toxin and Related Neurological Disorders (Clinical Neurology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 50 references in the paper

Abstract

Introduction: Stroke often causes spasticity, impacting mobility and quality of life. Botulinum Toxin type A (BTX-A) and Dry Needling (DN) are treatments that reduce spasticity, although Botulinum Toxin type A injections can cause adverse effects. No studies have directly compared their effects at spinal, muscular, functional, quality-of-life, and cost-effectiveness levels. This study aims to determine the spinal mechanisms of BTX-A and DN on post-stroke lower limb spasticity, while also assessing feasibility, safety, and exploratory effects at muscular, functional, quality-of-life, and cost-effectiveness levels.

Methods and analysis: This is a protocol of a proof-of-concept, feasibility randomized clinical trial including 90 participants from Canada, Belgium, and Spain who experienced a first stroke in the previous 12 months and present plantar flexor spasticity. Time since stroke (0–12 months) will be recorded and explored as a potential modifier of treatment response. Participants will be randomly assigned to receive either one session of BTX-A or 12 weekly sessions of DN. Blinded evaluators will assess outcomes before, during, and after treatment, with a 4-week follow-up. The primary outcome will be spinal mechanisms of spasticity, measured using the Tonic Stretch Reflex Threshold and its velocity sensitivity. Secondary outcomes will assess: a) muscular architecture and echotexture (measured with ultrasound); b) muscle tone/resistance using the Modified Ashworth Scale; c) gait and mobility (instrumented analysis, Timed Up and Go, 10-Meter Walk Test); d) muscle strength with dynamometry; e) quality of life with the EuroQoL questionnaire; and f) cost-effectiveness (analytic model). The findings will provide preliminary data to inform a future definitive trial.

Ethics and Dissemination: This research project has secured funding from the NEURON ERA-NET 2022 call, supported by the European Union’s Horizon 2020 program (GA 964215) and co-funded by the European Union-Next Generation, and has undergone peer review. Ethical approval has been obtained from Spain, Canada, and Belgium. The study is registered in ClinicalTrials.gov (NCT06296082) and the Clinical Trials Information System (CTIS) under the number 2024-510866-18-00. The study protocol is registered on Zenodo (https://doi.org/10.5281/zenodo.20034064)

Clinical Trials: Clinical Trials NCT06296082; https://clinicaltrials.gov/study/NCT06296082

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability

The study protocol and supporting documentation are publicly available on Zenodo at https://doi.org/10.5281/zenodo.20034064 (CC BY 4.0). Participant-level data are not yet available as data collection has not commenced. Anonymized data will be deposited in the same repository upon study completion.

Reproduced under the paper's license (CC BY), from the paper cited above.

Data deposition and curation

The STROKE-POC project data are publicly available on Zenodo at https://doi.org/10.5281/zenodo.20034064 (CC BY 4.0). Mean/median values for missing data will be imputed. Double data-entry and automated range checks will be implemented; details are described in the trial’s Data Management Plan available on request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added European Commission: 964215; Fonds Wetenschappelijk Onderzoek: 49317; Fonds de Recherche du Québec - Santé: 324226; Instituto de Salud Carlos III: AC22/00016; H2020 European Institute of Innovation and Technology: GA 964215

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 19 MeSH terms, 47 references.

Cite

This paper

Pujol-Fuentes, C., Eeckhaut, B., Fernández Carnero, S., Fernández Sanchís, D., Wein, T., Herrero, P., Saeys, W., & Levin, M. F. (2026). Spinal mechanisms and feasibility of Dry Needling versus Botulinum Toxin Type A in post-stroke lower limb spasticity: A proof-of-concept randomized clinical trial protocol (STROKE-POC). PloS one, 21(5), e0334571. https://doi.org/10.1371/journal.pone.0334571

BibTeX

@article{pujolfuentes2026spinal,
author = {Pujol-Fuentes, Clara and Eeckhaut, Bart and Fernández Carnero, Samuel and Fernández Sanchís, Daniel and Wein, Theodore and Herrero, Pablo and Saeys, Wim and Levin, Mindy F},
title = {{Spinal mechanisms and feasibility of Dry Needling versus Botulinum Toxin Type A in post-stroke lower limb spasticity: A proof-of-concept randomized clinical trial protocol (STROKE-POC)}},
journal = {PloS one},
year = {2026},
month = may,
volume = {21},
number = {5},
pages = {e0334571},
publisher = {PLOS},
issn = {1932-6203},
doi = {10.1371/journal.pone.0334571},
url = {https://doi.org/10.1371/journal.pone.0334571},
pmid = {42160369},
pmcid = {PMC13189288}
}

RIS

TY - JOUR
AU - Pujol-Fuentes, Clara
AU - Eeckhaut, Bart
AU - Fernández Carnero, Samuel
AU - Fernández Sanchís, Daniel
AU - Wein, Theodore
AU - Herrero, Pablo
AU - Saeys, Wim
AU - Levin, Mindy F
TI - Spinal mechanisms and feasibility of Dry Needling versus Botulinum Toxin Type A in post-stroke lower limb spasticity: A proof-of-concept randomized clinical trial protocol (STROKE-POC)
T2 - PloS one
J2 - PLoS One
PY - 2026
DA - 2026/05/20
VL - 21
IS - 5
SP - e0334571
SN - 1932-6203
PB - PLOS
DO - 10.1371/journal.pone.0334571
UR - https://doi.org/10.1371/journal.pone.0334571
LA - en
ER -

CSL-JSON

{
"id": "10.1371/journal.pone.0334571",
"type": "article-journal",
"title": "Spinal mechanisms and feasibility of Dry Needling versus Botulinum Toxin Type A in post-stroke lower limb spasticity: A proof-of-concept randomized clinical trial protocol (STROKE-POC)",
"container-title": "PloS one",
"author": [
{
"family": "Pujol-Fuentes",
"given": "Clara"
},
{
"family": "Eeckhaut",
"given": "Bart"
},
{
"family": "Fernández Carnero",
"given": "Samuel"
},
{
"family": "Fernández Sanchís",
"given": "Daniel"
},
{
"family": "Wein",
"given": "Theodore"
},
{
"family": "Herrero",
"given": "Pablo"
},
{
"family": "Saeys",
"given": "Wim"
},
{
"family": "Levin",
"given": "Mindy F"
}
],
"container-title-short": "PLoS One",
"volume": "21",
"issue": "5",
"page": "e0334571",
"DOI": "10.1371/journal.pone.0334571",
"PMID": "42160369",
"PMCID": "PMC13189288",
"ISSN": "1932-6203",
"publisher": "PLOS",
"URL": "https://doi.org/10.1371/journal.pone.0334571",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
20
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fbioe.2022.897852 [code]
Revising the stretch reflex threshold method to measure stretch hyperreflexia in cerebral palsy.
Journal: Frontiers in bioengineering and biotechnology
In common: 4 references
[2] doi:10.3390/biomedicines12061348
Effects of Cerebellar Non-Invasive Stimulation on Neurorehabilitation in Stroke Patients: An Updated Systematic Review.
Journal: Biomedicines
In common: stroke, clinical / translational, 2 references
[3] doi:10.1002/alz.13913
"Brain-IT": Exergame training with biofeedback breathing in neurocognitive disorders.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
In common: clinical / translational, 2 references
[4] doi:10.2196/41173
Effectiveness of an Individualized Exergame-Based Motor-Cognitive Training Concept Targeted to Improve Cognitive Functioning in Older Adults With Mild Neurocognitive Disorder: Study Protocol for a Randomized Controlled Trial.
Journal: JMIR research protocols
In common: clinical / translational, 2 references
[5] doi:10.1186/s12984-026-01906-x
Preventing slowing down of alpha rhythms in stroke patients through modulation of cortical excitatory-inhibitory balance: a randomized controlled trial.
Journal: Journal of neuroengineering and rehabilitation
In common: stroke, clinical / translational, 1 reference
[6] doi:10.1093/ptj/pzae148
Modeling Upper Limb Rehabilitation-Induced Recovery After Stroke: The Role of Attention as a Clinical Confounder.
Journal: Physical therapy
In common: stroke, clinical / translational, 1 reference
[7] doi:10.1186/s13063-026-09449-1
Noninvasive BCI-based cognitive rehabilitation in poststroke cognitive impairment: study protocol for a randomized controlled trial.
Journal: Trials
In common: stroke, clinical / translational, 1 reference
[8] doi:10.1186/s42466-024-00334-3
Multidisciplinary lifestyle interventions for neurological disorders during the Silent phase (MINDS) study: a multi-omics randomized controlled trial protocol.
Journal: Neurological research and practice
In common: stroke, clinical / translational, 1 reference
[9] doi:10.1186/s13063-022-06596-z
Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.
Journal: Trials
In common: stroke, clinical / translational, 1 reference
[10] doi:10.1113/jp282609 [code]
Investigation of neural and biomechanical impairments leading to pathological toe and heel gaits using neuromusculoskeletal modelling.
Journal: The Journal of physiology
In common: stroke, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.